Home / Mesalazine / Czechia
CZ ATC A07EC02 · updated 2 Nov 2026
Mesalazine shortage in Czechia
Is there a Mesalazine shortage in Czechia?
Yes. As of 2 Nov 2026, 3 Mesalazine products are reported short in Czechia, the first since 17 Jul 2024. The company estimate for the return is 1 Mar 2027 (latest 31 Dec 2028). Main reason: manufacturing problem.
Also short in Canada, Germany, France, Ireland, Austria, Norway, Sweden, Japan, New Zealand, Australia. All countries.
Affected products in Czechia
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CZ | SALOFALK 500MG 500MG GRA PRO 100 | Dr. Falk Pharma GmbH, Freiburg | 17 Jul 2024 | 31 Dec 2028 | Commercial decision or withdrawal Obchodní/marketingové důvody |
| CZ | SALOFALK 3000MG 3000MG GRA PRO 60 | Dr. Falk Pharma GmbH, Freiburg | 1 Nov 2026 | 30 Apr 2027 | Manufacturing problem Výrobní důvody |
| CZ | SALOFALK 1G 1G SUP 30 anticipated | Dr. Falk Pharma GmbH, Freiburg | 1 Dec 2026 | 1 Mar 2027 | Manufacturing problem Výrobní důvody |
Source
SÚKL (State Institute for Drug Control), market reports. Official list. Products whose latest market report is a supply interruption; one row per SÚKL code.